BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25794698)

  • 1. Lumbar total disc replacement by less invasive lateral approach: a report of results from two centers in the US IDE clinical trial of the XL TDR® device.
    Tohmeh AG; Smith WD
    Eur Spine J; 2015 Apr; 24 Suppl 3():331-8. PubMed ID: 25794698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motion preservation following total lumbar disc replacement at the lumbosacral junction: a prospective long-term clinical and radiographic investigation.
    Wuertinger C; Annes RDÀ; Hitzl W; Siepe CJ
    Spine J; 2018 Jan; 18(1):72-80. PubMed ID: 28673830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar total disc replacement from an extreme lateral approach: clinical experience with a minimum of 2 years' follow-up.
    Pimenta L; Oliveira L; Schaffa T; Coutinho E; Marchi L
    J Neurosurg Spine; 2011 Jan; 14(1):38-45. PubMed ID: 21166491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes.
    McAfee PC; Cunningham B; Holsapple G; Adams K; Blumenthal S; Guyer RD; Dmietriev A; Maxwell JH; Regan JJ; Isaza J
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1576-83; discussion E388-90. PubMed ID: 16025025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 lumbar total disc replacements: results of a prospective, randomized, controlled, multicenter Food and Drug Administration trial with 24-month follow-up.
    Guyer RD; Pettine K; Roh JS; Dimmig TA; Coric D; McAfee PC; Ohnmeiss DD
    Spine (Phila Pa 1976); 2014 May; 39(12):925-31. PubMed ID: 24718066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease.
    Zigler JE; Delamarter RB
    J Neurosurg Spine; 2012 Dec; 17(6):493-501. PubMed ID: 23082846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-level total disc replacement with Mobi-C cervical artificial disc versus anterior discectomy and fusion: a prospective, randomized, controlled multicenter clinical trial with 4-year follow-up results.
    Davis RJ; Nunley PD; Kim KD; Hisey MS; Jackson RJ; Bae HW; Hoffman GA; Gaede SE; Danielson GO; Gordon C; Stone MB
    J Neurosurg Spine; 2015 Jan; 22(1):15-25. PubMed ID: 25380538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- to long-term results of total lumbar disc replacement: a prospective analysis with 5- to 10-year follow-up.
    Siepe CJ; Heider F; Wiechert K; Hitzl W; Ishak B; Mayer MH
    Spine J; 2014 Aug; 14(8):1417-31. PubMed ID: 24448028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a mismatched center of rotation on the clinical outcomes and flexion-extension range of motion: lumbar total disk replacement using mobidisc at a 5.5-year follow-up.
    Lee CS; Lee DH; Hwang CJ; Kim H; Noh H
    J Spinal Disord Tech; 2014 May; 27(3):148-53. PubMed ID: 22525508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH; Schranck FW; Copay AG
    J Neurosurg Spine; 2019 May; 31(3):347-356. PubMed ID: 31100723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental contribution toward total lumbar range of motion in disc replacement and fusions: a comparison of operative and adjacent levels.
    Auerbach JD; Jones KJ; Milby AH; Anakwenze OA; Balderston RA
    Spine (Phila Pa 1976); 2009 Nov; 34(23):2510-7. PubMed ID: 19927100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar Total Disc Replacement by the Lateral Approach-Up to 10 Years Follow-Up.
    Pokorny G; Marchi L; Amaral R; Jensen R; Pimenta L
    World Neurosurg; 2019 Feb; 122():e325-e333. PubMed ID: 30326312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization with the Dynamic Cervical Implant: a novel treatment approach following cervical discectomy and decompression.
    Matgé G; Berthold C; Gunness VR; Hana A; Hertel F
    J Neurosurg Spine; 2015 Mar; 22(3):237-45. PubMed ID: 25555050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical results following Charite III lumbar total disc replacement.
    Lu S; Sun S; Kong C; Sun W; Hu H; Wang Q; Hai Y
    Spine J; 2018 Jun; 18(6):917-925. PubMed ID: 28870839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease.
    Lu SB; Hai Y; Kong C; Wang QY; Su Q; Zang L; Kang N; Meng XL; Wang Y
    Eur Spine J; 2015 Sep; 24(9):2056-64. PubMed ID: 25895882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Clinical and Radiographic Results of Activ L Total Disk Replacement at 1- to 3-Year Follow-up.
    Lu S; Kong C; Hai Y; Kang N; Zang L; Wang Y; Yuan Y
    J Spinal Disord Tech; 2015 Nov; 28(9):E544-50. PubMed ID: 25532603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiological outcome at 10 years of follow-up after total cervical disc replacement.
    Mehren C; Heider F; Siepe CJ; Zillner B; Kothe R; Korge A; Mayer HM
    Eur Spine J; 2017 Sep; 26(9):2441-2449. PubMed ID: 28676980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinical Outcomes of 1- and 2-Level Total Disc Replacement: Four-Year Results From a Prospective, Randomized, Controlled, Multicenter IDE Clinical Trial.
    Bae HW; Kim KD; Nunley PD; Jackson RJ; Hisey MS; Davis RJ; Hoffman GA; Gaede SE; Danielson GO; Peterson DL; Stokes JM; Araghi A
    Spine (Phila Pa 1976); 2015 Jun; 40(11):759-66. PubMed ID: 25785955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
    Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
    J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.